<?xml version="1.0" encoding="UTF-8"?>
<ref id="pmed.1002422.ref055">
 <label>55</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Deutsch</surname>
   <given-names>MB</given-names>
  </name>, 
  <name>
   <surname>Glidden</surname>
   <given-names>DV</given-names>
  </name>, 
  <name>
   <surname>Sevelius</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Keatley</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>McMahan</surname>
   <given-names>V</given-names>
  </name>, 
  <name>
   <surname>Guanira</surname>
   <given-names>J</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial</article-title>. 
  <source>Lancet HIV</source>. 
  <year>2015</year>;
  <volume>2</volume>(
  <issue>12</issue>):
  <fpage>e512</fpage>â€“
  <lpage>9</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S2352-3018(15)00206-4" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/S2352-3018(15)00206-4</ext-link>
  </comment>
  <?supplied-pmid 26614965?>
  <pub-id pub-id-type="pmid">26614965</pub-id>
 </mixed-citation>
</ref>
